Selpercatinib(Retevmo)

Selpercatinib is a highly selective and potent kinase inhibitor that exerts its therapeutic effect by selectively targeting and inhibiting mutated or fusion forms of the RET gene.

40mg*120capsules

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Selpercatinib Medication Guide

Selpercatinib Indications: FDA-Approved RET Fusion-Positive Cancers

Selpercatinib is a treatment option recommended by the National Comprehensive Cancer Network (NCCN) for certain patients with RET-positive metastatic ···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 71
What side effects can selpercatinib cause?

If you experience side effects, your doctor may change your dose, temporarily stop, or permanently discontinue treatment with selpercatinib. Do not ch···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 71